Matches in Wikidata for { <http://www.wikidata.org/entity/Q67127594> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q67127594 description "clinical trial" @default.
- Q67127594 description "ensayu clínicu" @default.
- Q67127594 description "klinisch onderzoek" @default.
- Q67127594 description "клінічне випробування" @default.
- Q67127594 name "An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer" @default.
- Q67127594 name "An Efficacy and Safety Study of Erdafitinib" @default.
- Q67127594 type Item @default.
- Q67127594 label "An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer" @default.
- Q67127594 label "An Efficacy and Safety Study of Erdafitinib" @default.
- Q67127594 prefLabel "An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer" @default.
- Q67127594 prefLabel "An Efficacy and Safety Study of Erdafitinib" @default.
- Q67127594 P1132 Q67127594-07F59FE1-5DE7-47BB-B39D-AAD3248B0F21 @default.
- Q67127594 P1476 Q67127594-B16E8C8E-0386-47BB-A86E-839BEED82BDE @default.
- Q67127594 P17 Q67127594-1865C07D-D885-4337-86D6-36618581B388 @default.
- Q67127594 P17 Q67127594-1AF3AC92-5281-4BA6-A4A6-39EFD6BF0800 @default.
- Q67127594 P17 Q67127594-20A0068E-B5BC-41BA-89D5-6464170DAB86 @default.
- Q67127594 P17 Q67127594-468EF1C0-B5F0-4770-BB20-2D0DC724114B @default.
- Q67127594 P17 Q67127594-55D00BEF-7106-4BCF-9566-C26C8A48E267 @default.
- Q67127594 P17 Q67127594-A91D7F93-E629-42CC-AB1F-8FB3520355A0 @default.
- Q67127594 P17 Q67127594-AA6BEE0C-5FAC-4A76-ABC1-C5F8659881F0 @default.
- Q67127594 P17 Q67127594-C24F8B7E-9322-44F1-BA57-0834DAF83A2E @default.
- Q67127594 P17 Q67127594-D6CE1F88-DDA6-4F7F-B585-E9F5F43F5354 @default.
- Q67127594 P17 Q67127594-FD09EE82-17F8-4EA4-98B4-C4394FAD00D1 @default.
- Q67127594 P2899 Q67127594-8C6ED056-E78A-457E-8673-7AD0FFF09FCB @default.
- Q67127594 P3098 Q67127594-A3DD49F3-4F0A-4077-86E0-609607022B18 @default.
- Q67127594 P31 Q67127594-303793C2-85C8-436D-B693-F51BF0478F80 @default.
- Q67127594 P580 Q67127594-AF4BD771-C6AE-4701-84A0-1F67BAA465B9 @default.
- Q67127594 P582 Q67127594-A7C173A2-9159-4215-819C-7EEC58B80C2C @default.
- Q67127594 P6099 Q67127594-C06F22E9-827E-4661-9206-7A26C03C5BBB @default.
- Q67127594 P8363 Q67127594-028D743F-1B8E-4121-B430-BB6B2D2A9592 @default.
- Q67127594 P1132 "+216" @default.
- Q67127594 P1476 "A Phase 2, Two-arm Multicenter, Open-Label Study to Determine the Efficacy and the Safety of Two Different Dose Regimens of a Pan-FGFR Tyrosine Kinase Inhibitor JNJ-42756493 in Subjects With Metastatic or Surgically Unresectable Urothelial Cancer With FGFR Genomic Alterations" @default.
- Q67127594 P17 Q142 @default.
- Q67127594 P17 Q145 @default.
- Q67127594 P17 Q183 @default.
- Q67127594 P17 Q218 @default.
- Q67127594 P17 Q29 @default.
- Q67127594 P17 Q30 @default.
- Q67127594 P17 Q31 @default.
- Q67127594 P17 Q40 @default.
- Q67127594 P17 Q801 @default.
- Q67127594 P17 Q865 @default.
- Q67127594 P2899 "+18" @default.
- Q67127594 P3098 "NCT02365597" @default.
- Q67127594 P31 Q30612 @default.
- Q67127594 P580 "2015-04-22T00:00:00Z" @default.
- Q67127594 P582 "2019-09-26T00:00:00Z" @default.
- Q67127594 P6099 Q42824440 @default.
- Q67127594 P8363 Q78089383 @default.